1240419

CorePharma, LLC — FEI 3002535019

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Middlesex, NJ (United States)